Value 40%
How cheap is BMY compared to other Healthcare stocks? Lower forward P/E, EV/EBITDA, and P/FCF earn higher Value scores.
71.6
- Forward P/E
- 9.50
- EV / EBITDA
- 10.11
- P / FCF
- 8.57
- PEG
- n/m
BMY Bristol-Myers Squibb Company
67.1
Opportunity
Raw BEACON composite
How to read this page
The big number above is BMY's BEACON composite — a 0-100 sector-relative score blending three factors: Value (40%), Quality (35%), and Momentum (25%). A score of 70+ means BMY ranks well against its Healthcare peers on most factors. The current macro regime is then overlaid to produce the regime-adjusted score lower on this page.
Every metric on this page is computed against Healthcare peers, not the whole market. A "cheap" P/E in tech isn't the same as a "cheap" P/E in utilities. Read the full methodology →
Quality 35%
How healthy is the underlying business? Higher gross margin, ROE, and FCF yield (and lower debt) earn higher Quality scores.
63.3
- Gross Margin
- +67.7%
- ROE
- +38.2%
- Debt / Equity
- 2.55
- FCF Yield
- +11.67%
Momentum 25%
Is the market starting to recognize the value? Above the 200-day moving average and a positive 3-month return earn higher Momentum scores.
65.0
- Price
- $59.47
- 200-day SMA
- $50.89
- vs 200-day
- +16.9%
- 3-month change
- +6.5%
BMY vs Healthcare Median
Each row compares BMY to the median stock in the Healthcare sector. ▲ Better means BMY is better positioned than the sector median for that metric (cheaper for valuation metrics, healthier for quality metrics). ▼ Worse means the opposite. Tiny differences (within 2%) are shown as In line.
| Metric | BMY | Healthcare Median | vs Median |
|---|---|---|---|
| Forward P/E | 9.50 | 11.87 | ▲ Better |
| EV / EBITDA | 10.11 | 9.00 | ▼ Worse |
| P / FCF | 8.57 | 10.33 | ▲ Better |
| PEG Ratio | n/m | 0.09 | ▼ n/m |
| Gross Margin | +67.7% | +64.2% | ▲ Better |
| ROE | +38.2% | -6.6% | ▲ Better |
| Debt / Equity | 2.55 | 0.27 | ▼ Worse |
| FCF Yield | +11.7% | +0.9% | ▲ Better |
Regime Fit
The current macro regime favors some sectors and pressures others. BEACON multiplies BMY's raw score by a sector-specific multiplier to produce its regime-adjusted score. The regime contribution below is how many score points the overlay added (or subtracted) for this stock.
Current regimeEXPANSION
Confidence70.0%
Fit► Neutral
Base multiplier1.00x
Effective multiplier1.00x
Regime contribution0.0 pts
Raw BEACON67.1
Regime-adjusted67.1
Global rank#55
Sector rank#7 / 150
Financial Health
These five indicators drive BEACON's hard red-flag gates. If any of them lands in the red zone, the composite score is capped at 40 regardless of how the Value/Quality/Momentum sub-scores look. Refreshed weekly from BMY's most recent annual filings.
Altman Z-Score
2.19
Grey Zone
≥ 3.0 safe · 1.81-2.99 grey · < 1.8 distress
Current Ratio
1.26
Adequate
≥ 1.5 healthy · 1.0-1.49 adequate · < 0.5 critical
Revenue YoY Growth
-0.2%
Declining
≥ +5% growing · 0 to -15% declining · < -15% sharp
Consecutive Negative FCF Years
0
None
3+ years triggers a red flag
Consecutive Revenue Decline Years
1
1 year
2+ years (combined w/ -15% YoY) triggers a red flag
Interested in gold & mining?
GoldStockData rates 850+ precious metals miners on 11 quantitative signal layers.
Visit GoldStockData →